Clinical Trials List
Protocol Number100-4356A
Not yet recruiting
2012-08-01 - 2015-12-31
Phase II
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 林衛邑 Division of Neurology
- Kun-Ju Lin Division of Nuclear Medicine
- 陸清松 Division of Neurology
- Rou-Shayn Chen Division of Neurology
- Kuan-Yi Wu Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
140 participants
-
Global
0 participants
